Home > Insider Trading > Filing (0000899243-19-013218)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1217234	Caredx Inc.	CDNA	Services-Medical Laboratories (8071)	943316839

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1702824	Brian Michael Bell	C/O Caredx, Inc. 3260 Bayshore Boulevard Brisbane CA 94005	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-08-14	12,500	$1.00	93,593	No	4	M	Direct
Common Stock	Disposition	2018-08-14	12,500	$16.84	81,093	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2018-08-14	12,500	$0.00	12,500	$1.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
37,500		2027-04-21	No	4	M	Direct

Footnotes

This amendment is being filed to report the exercise of an option to purchase 12,500 shares of common stock by the Reporting Person on August 14, 2018 which was inadvertently omitted from the original Form 4. This exercise resulted in an additional 12,500 shares held by the Reporting Person which were inadvertently omitted from the original Form 4 and also were omitted from five Forms 4 filed by the Reporting Person after the date the original Form 4 was filed.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.75 to $17.045, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
1/4th of the shares subject to the option vested on April 21, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.